Financial Performance - The company's operating revenue for 2023 was CNY 6,293,638,808.28, a decrease of 0.23% compared to the previous year[3] - Net profit attributable to shareholders was CNY 124,202,715.83, down 34.97% year-on-year[5] - Net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 110,759,200.51, a decline of 40.10% compared to the previous year[5] - Basic earnings per share decreased to CNY 0.44, down 39.45% year-on-year[5] Assets and Equity - Total assets at the end of the reporting period were CNY 2,128,438,222.14, a decrease of 1.59% from the beginning of the period[5] - Shareholders' equity attributable to the company increased to CNY 1,437,803,150.69, up 18.71% from the beginning of the period[5] - The company's share capital increased by 11.46% to CNY 291,132,748.00 due to public stock issuance[6] Market Conditions - The decline in revenue and net profit was primarily due to intensified competition in the chemical industry and a general downturn in market demand[5] - The company experienced investment losses from foreign exchange derivatives, impacting net profit[5] Reporting Status - The financial data presented is preliminary and unaudited, with final figures to be disclosed in the annual report[7]
一诺威(834261) - 2023 Q4 - 年度业绩